The ROE as of December 2025 (TTM) for Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) is -54.75%

According to Infant Bacterial Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current ROE is -54.75%. This represents a change of 312.52% compared to the average of -13.27% of the last 4 quarters.

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) Historical ROE (quarterly & annually)

How has IBT-B.ST ROE performed in the past?

The mean historical ROE of Infant Bacterial Therapeutics AB (publ) over the last ten years is -27.00%. The current -54.75% ROE has changed 102.74% with respect to the historical average. Over the past ten years (40 quarters), IBT-B.ST's ROE was at its highest in in the December 2015 quarter at 6.45%. The ROE was at its lowest in in the December 2024 quarter at -19.83%.

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Infant Bacterial Therapeutics AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) Average ROE

How has IBT-B.ST ROE performed in the past?

The current ROE of Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) ROE vs. Peers

How is IBT-B.ST’s ROE compared to its peers?

Infant Bacterial Therapeutics AB (publ)’s ROE is greater than Xspray Pharma AB (publ) (-36.36%), less than Cantargia AB (publ) (108.71%), less than Oncopeptides AB (publ) (9.01%), greater than Senzime AB (publ) (-35.18%), greater than SynAct Pharma AB (-54.05%), less than I-Tech AB (25.10%), greater than Corline Biomedical AB (-29.03%), greater than Guard Therapeutics International AB (publ) (-204.93%), less than ADDvise Group AB (publ) (0.46%), less than Xintela AB (publ) (245.05%),

Build a custom stock screener for Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Infant Bacterial Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Infant Bacterial Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.